RT Journal Article
SR Electronic
T1 Effect of gut microbiota on colorectal cancer progression and treatment
JF Saudi Medical Journal
JO Saudi Med J
FD Prince Sultan Military Medical City
SP 1289
OP 1299
DO 10.15537/smj.2022.43.12.20220367
VO 43
IS 12
A1 Glowi A. Alasiri
YR 2022
UL http://smj.org.sa/content/43/12/1289.abstract
AB Microbiota is a collection of bacteria, archaea, eukaryotes, bacteriophages, viruses, and fungi that cover human body surfaces and cavities. They characterize inside the body due to several factors such as diet, nutrition, xenobiotic substances, and microbial infections. Several studies have shown that gut microbiota can induce resistance against pathogens and regulate the immune system. In addition, their disruption is associated with several physiological and biochemical disorders, including inflammatory bowel disease (IBD), obesity, autoimmune diseases such as diabetes, hypertension, colon cancer, and cardiovascular disease. Colorectal cancer (CRC) is the third-deadliest cancer worldwide, accounting for approximately 900,000 deaths per year globally. Gut microbiota has been heavily linked to CRC incidence and prevention via bacterial metabolites, invasion, translocation, host’s defense modulations, and bacterial-immune system interactions. In addition, it can influence the metabolism of chemical compounds such as drugs and xenobiotics to manipulate the treatment response in CRC patients.